Travoprost acid
|
221246-34-0
|
221246-34-0
|
BNC105
|
BNC105
|
945771-74-4
|
Mavacamten
|
瑪伐凱泰
|
1642288-47-8
|
UT-155
|
UT-155
|
2031161-35-8
|
RuPhos Pd G3
|
甲磺酸(2-二環(huán)己基膦基-2',6'-二異丙氧基-1,1'-聯(lián)苯基)(2-氨基-1,1'-聯(lián)苯-2-基)鈀(II)
|
1445085-77-7
|
Ribociclib succinate
|
瑞博西尼琥珀酸鹽
|
1374639-75-4
|
AT-527
|
AT-527
|
2241337-84-6
|
ADX-102 (NS-2)
|
REPROXALAP
|
916056-79-6
|
NI-42
|
NI-42
|
1884640-99-6
|
UCB9608
|
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺
|
1616413-96-7
|
PSI-6130
|
2'-去氧-2'-氟-2'-C-甲基胞苷
|
817204-33-4
|
PHA-665752
|
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氫-2-氧代-3H-吲哚-3-亞基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷
|
477575-56-7
|
BMS-986195
|
BMS-986195
|
1912445-55-6
|
AS602801(BentaMapiMod)
|
本塔馬莫
|
848344-36-5
|
Astemizole(R43512)
|
阿司咪唑
|
68844-77-9
|
Mericitabine (RG-7128)
|
(2'R)- 2'-去氧-2'-氟-2'-甲基胞苷 3',5'-雙(2-甲基丙酸)酯
|
940908-79-2
|
KN-93 hydrochloride
|
化合物 T21557
|
1956426-56-4
|
ApiliMod
|
阿吡莫德
|
541550-19-0
|
FB23
|
FB23
|
2243736-35-6
|
NCT-503
|
NCT503
|
1916571-90-8
|
EGFR Inhibitor
|
EGFR INHIBITOR
|
879127-07-8
|
AdipoRon
|
阿迪普隆
|
924416-43-3
|
FN-1501
|
1429515-59-2
|
1429515-59-2
|
EGFR-IN-7
|
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺
|
2267329-76-8
|
Dynarrestin
|
Dynarrestin
|
2222768-84-3
|
OICR-9429
|
OICR-9429
|
1801787-56-3
|
WM3835
|
化合物WM-3835
|
2229025-70-9
|
JH-X-119-01
|
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
|
2227368-54-7
|
EN4
|
化合物EN4 MYC INHIBITOR
|
1197824-15-9
|
KB-0742 HCl
|
KB-0742 HCL
|
2416873-83-9
|
CID755673
|
2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one
|
521937-07-5
|
Vonafexor(PLX007,EYP-001)
|
YP001
|
1192171-69-9
|
NS 3623
|
NS 3623
|
343630-41-1
|
STING INHIBITOR-2
|
N-(3-(4-氟苯基磺酰氨基)-4-羥基苯基)-[1,1'-聯(lián)苯]-4-甲酰胺
|
2249435-90-1
|
Phthalazinone pyrazole
|
Phthalazinone pyrazole
|
880487-62-7
|
ML417
|
ML417
|
1386162-69-1
|
USL311
|
USL311
|
1373268-67-7
|
NS5806
|
NS 5806
|
426834-69-7
|
Sirtinol
|
2-[[(2-羥基-1-萘基)亞甲基]氨基]-N-(1-苯基乙基)苯甲酰胺
|
410536-97-9
|
UUN44923
|
Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-
|
2243944-92-3
|
SU14813
|
SU-14813
|
627908-92-3
|
Samatasvir
|
ATOLIHZIXHZSBA-BTSKBWHGSA-N
|
1312547-19-5
|
SR-717
|
SR-717
|
2375421-09-1
|
TAS-116
|
TAS-116
|
1260533-36-5
|
STING agonist-1 (G10)
|
702662-50-8
|
702662-50-8
|
Pax2 inhibitor EG1
|
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸 2級
|
693241-54-2
|
Pizuglanstat
|
化合物PIZUGLANSTAT
|
1244967-98-3
|
CCT245737
|
5-[[4-[[((2R)-2-嗎啉基甲基]氨基]-5-(三氟甲基)-2-吡啶基]氨基]-2-吡嗪腈
|
1489389-18-5
|
E3 ligase Ligand 5
|
1264754-13-3
|
1264754-13-3
|
MUN36378
|
化合物MUN36378
|
2243736-37-8
|
FB23-2
|
FB23-2
|
2243736-45-8
|
Amcasertib(BBI503)
|
AMCASERTIB
|
1129403-56-0
|
KX2-391
|
5-[4-[2-(4-嗎啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺
|
897016-82-9
|
NVP-BHG 712
|
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺
|
940310-85-0
|
PF-5274857
|
PF-5274857
|
1373615-35-0
|
ML267
|
4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide trifluoroacetate
|
1542213-67-1
|
BI-749327
|
BI-749327
|
2361241-23-6
|
SU0268
|
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]-
|
2210228-45-6
|
SJB2-043
|
2-苯基萘并[2,3-D]惡唑-4,9-二酮
|
63388-44-3
|
Apilimod mesylate
|
阿吡莫德甲磺酸鹽
|
870087-36-8
|
PF-06882961
|
PF-06882961
|
2230198-02-2
|
JNJ63576253 HCl
|
化合物JNJ63576253
|
2110428-64-1
|
BI-D1870
|
BI-D1870
|
501437-28-1
|
GSK 2118436(SB 590885)
|
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氫-1-茚酮肟
|
405554-55-4
|
dCBP-1
|
化合物DCBP-1
|
2484739-25-3
|
GNE-781
|
GNE-781
|
1936422-33-1
|
YQ128
|
化合物YQ128
|
2454246-18-3
|
PF-06873600
|
PF-06873600
|
2185857-97-8
|
BC1618
|
化合物BC1618
|
2222094-18-8
|
Endovion
|
ENDOVION
|
265646-85-3
|
MB-07344
|
((4-(4-羥基-3-異丙基苯甲基)-3,5-二甲基苯氧基)甲基)膦酸
|
852947-39-8
|
BRM/BRG1 ATP Inhibitor-1
|
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA
|
2270879-17-7
|
SP-13786
|
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺
|
1448440-52-5
|
Nifenalol hydrochloride
|
硝苯洛爾鹽酸鹽
|
5704-60-9
|
N-methyl-2-pyrrolidin-1-yl-ethanamine
|
N-甲基-2-吡咯烷-1-基乙胺二鹽酸鹽
|
32776-22-0
|
Paricalcitol
|
帕立骨化醇
|
131918-61-1
|
Maxacalcitol
|
馬沙骨化醇
|
103909-75-7
|
Lasmiditan succinate
|
琥珀酸拉斯米迪坦
|
439239-92-6
|
GNE-317
|
5-[6-(3-甲氧基-3-氧雜環(huán)丁基)-7-甲基-4-(4-嗎啉基)噻吩并[3,2-d]嘧啶-2-基]-2-嘧啶胺
|
1394076-92-6
|
AG-270
|
3-(1-環(huán)己烯-1-基)-6-(4-甲氧基苯基)-2-苯基-5-(2-吡啶基氨基)吡唑[1,5-A]嘧啶-7(4H)-酮
|
2201056-66-6
|
Ro60-0175
|
Ro 60-0175
|
169675-08-5
|
I-BET567
|
化合物I-BET567
|
1887237-54-8
|
GSK329
|
化合物GSK329
|
1268490-12-5
|
SGK1-IN-4
|
化合物SGK1-IN-4
|
1628048-93-0
|
CDK4/6-IN-6CDK4/CDK4/6-IN-66-IN-6
|
CDK4/6-IN-6
|
2380321-51-5
|
Azidamfenicol
|
疊氮氯霉素
|
13838-08-9
|
SBI-425
|
化合物SBI-425
|
1451272-71-1
|
AS2444697
|
AS-2444697
|
1287665-60-4
|
6,7-Difluoro-1H-benzoimidazole-2-carboxylic acid
|
6,7-二氟-1H-苯并[d]咪唑-2-羧酸
|
1225283-27-1
|
CapmatinibHClhydrate(INCB-28060)
|
鹽酸卡瑪替尼一水合物
|
1865733-40-9
|
V-9302 HCl
|
(S)-2-氨基-4-(bis(2-((3-甲基芐基)氧基)芐基)氨基)丁酸鹽酸鹽
|
2416138-42-4
|
Pyridine, 4-bromo-2-(difluoromethyl)-3-methyl-
|
4-溴-2-(二氟甲基)-3-甲基吡啶
|
1806777-93-4
|
MKC8866
|
MKC8866
|
1338934-59-0
|
ABT-724
|
2 - [(4-吡啶-2-基哌嗪-1-基)甲基]-1H-苯并咪唑 1級
|
70006-24-5
|
GSK-3β inhibitor 1
|
2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)-
|
187325-53-7
|
YM-58483
|
YM-5883
|
223499-30-7
|
NPS 2390
|
NPS 2390
|
226878-01-9
|
MAO-B-IN-2
|
化合物 MAO-B-IN-2
|
1253978-24-3
|
ZSTK474
|
2-(2-二氟甲基苯并咪唑-1-基)-4,6-二嗎啉基-1,3,5-三嗪
|
475110-96-4
|
HAT Inhibitor II
|
組蛋白乙酰轉(zhuǎn)移酶 抑制劑II
|
932749-62-7
|
PIPERAZIN-1-YL-PYRIDIN-3-YL-METHANONE
|
哌嗪-1-甲哌啶-3-基-甲酮
|
39640-08-9
|